Cited by 65Retinal Diseases and TreatmentsProteoglycans and glycosaminoglycans researchRetinal Development and Disorders

Age-dependent changes in heparan sulfate in human Bruch’s membrane: Implications for age-related macular degeneration

Keenan, Tiarnan D. L., Pickford, Claire E., Holley, Rebecca J., Clark, Simon J., Lin, Wanchang, Dowsey, Andrew W., Merry, Catherine L., Day, Anthony J. +1 more·2014·Investigative Opthalmology & Visual Science

Abstract

PURPOSE: Heparan sulfate (HS) has been implicated in age-related macular degeneration (AMD), since it is the major binding partner for complement factor H (CFH) in human Bruch's membrane (BrM), and CFH has a central role in inhibiting complement activation on extracellular matrices. The aim was to investigate potential aging changes in HS quantity and composition in human BrM. METHODS: Postmortem human ocular tissue was obtained from donors without known retinal disease. The HS was purified from BrM and neurosensory retina, and after digestion to disaccharides, fluorescently labeled and analyzed by reverse-phase HPLC. The HS and heparanase-1 were detected by immunohistochemistry in macular tissue sections from young and old donors, and binding of exogenously applied recombinant CCP6-8 region of CFH (402Y and 402H variants) was compared. RESULTS: Disaccharide analysis demonstrated that the mean quantity of HS in BrM was 50% lower (P = 0.006) in old versus young donors (average 82 vs. 32 years). In addition, there was a small, but significant decrease in HS sulfation in old BrM. Immunohistochemistry revealed approximately 50% (P = 0.02) less HS in macular BrM in old versus young donors, whereas heparanase-1 increased by 24% in old macular BrM (P = 0.56). In young donor tissue the AMD-associated 402H CCP6-8 bound relatively poorly to BrM, compared to the 402Y form. In BrM from old donors, this difference was significantly greater (P = 0.019). CONCLUSIONS: The quantity of HS decreases substantially with age in human BrM, resulting in fewer binding sites for CFH and especially affecting the ability of the 402H variant of CFH to bind BrM.

Integrity signals

Registry

Crossref · 10.1167/iovs.14-14126

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Keenan, T. D. L., Pickford, C. E., Holley, R. J., Clark, S. J., Lin, W., Dowsey, A. W., Merry, C. L., Day, A. J., & Bishop, P. N.
Affiliations
  • Centre for Hearing & Vision Research, Institute of Human Development, University of Manchester, Manchester, United Kingdom
  • University of Manchester (GB)
  • Wellcome Centre for Cell-Matrix Research (GB)
  • Manchester Academic Health Science Centre (GB)
Corresponding author
Bishop, Paul N.
Venue
Investigative Opthalmology & Visual Science
Published
2014-08-26
Volume
55
Issue
8
Pages
5370
ISSN
  • 0146-0404 (ISSN-L)
  • 1552-5783
OpenAlex
W2068819302
Cited by
65
References
61
Citations by year
2026: 4 · 2025: 6 · 2024: 4 · 2023: 3 · 2022: 4 · 2021: 7 · 2020: 5 · 2019: 4 · 2018: 4 · 2017: 7 · 2016: 7 · 2015: 7 · 2014: 3
FWCI
7.50
Type
journal article
Language
en
Open access
closed
Locations
  • Investigative Ophthalmology & Visual Science (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion)
  • Explore Bristol Research (submittedVersion)
Funders
Medical Research Council (MR/K024418/1, MR/K004441/1)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinal Development and Disorders
Keywords
heparan sulfate, Bruch's membrane, age-related macular degeneration, complement factor H, heparanase, aging, sulfation, complement activation, extracellular matrix, neurosensory retina
MeSH terms
Adult, Age Factors, Aged, Aged, 80 and over, Aging, Cadaver, Female, Heparitin Sulfate, Heparan Sulfate, Humans, Macular Degeneration, Male, Middle Aged, Polysaccharide-Lyases, Retina, Bruch Membrane, Chromatography, Reverse-Phase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review